Clinical Trial Update: Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating temozolomide with radiation therapy with or without bevacizumab in newly diagnosed glioblastoma; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Glioblastoma, Gliosarcoma | Phase 3 | Status: COMPLETED | Results posted: 2016-10-12